DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9597nj/enteric_disease) has announced the addition of the "Global Enteric Disease Testing Market Forecasts & Opportunities Report, 2019" report to their offering.
The global market is expected to reach USD 3,643.4 million by 2019, up from USD 3,082.6 million in 2012, growing at a CAGR of 2.4% throughout the forecast period.
Enteric diseases are gastrointestinal infections caused by a variety of microbes such as bacteria, viruses and parasites when they enter the body through the mouth or intestinal systems. Various microbes responsible for enteric infections include salmonella, shigella, rotavirus, norovirus, c. difficile, cryptosporidium, vibrio and campylobacter. These diseases may range from asymptomatic to having mild to severe symptoms such as bloody diarrhea, abdominal cramps, stool containing blood or pus, fever and weight loss. Incubation period varies from few days to few weeks depending on the disease and severity. In order to reduce the chance of developing complications, these diseases needed to be diagnosed early.
The market for the enteric disease testing market has been segmented on the basis of different types of enteric diseases and their testing. Earlier, diagnosis of enteric diseases relied on culture results of stool specimen that involved identification of causative pathogens in a culture medium. However, the trend is now shifting from culture methods to other diagnostic methods owing to limitations associated with culture tests. Major drawbacks associated with culture tests include high cost, labor intensive, requires sophisticated laboratory and a skilled person to perform the diagnosis.
On the other hand, enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) has made enteric infection diagnosis easy and fast. In developed regions such as North America and Europe, PCR based diagnosis is most recommended testing method for enteric diseases as it offers high sensitivity and specificity and is considered as easy, accurate, rapid and reliable method of diagnosis. Latest introductions in MALDI-TOF have also been developed for rapid diagnosis of whole organisms without destruction of infection sample.
Scope of the Report
Diseases
Bacterial Enteric Disease Testing Market
- C.difficile Infection
- Campylobacteriosis
- Cholera
- E.coli Infection
- H.pylori Infection
- Salmonellosis
- Shigellosis
Viral Enteric Disease Testing Market
- Rotavirus Infection
- Norovirus Infection
Parasitic Enteric Disease Testing Market
- Amebiasis
- Cryptosporidiosis
- Giardiasis
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Enteric Disease Testing Market Overview
Chapter 4 Global Enteric Disease Testing Market
Chapter 5 Global Enteric Disease Testing Market, By Geography, 2011 - 2019 (USD Million)
Chapter 6 Key Player Analysis for Enteric Disease Testing Market, 2012
Chapter 7 Company Profiles
- Alere, Inc
- Becton Dickinson & Company
- Biomerica, Inc
- Biomerieux
- Bio-Rad
- Cepheid
- Coris Bioconcept
- Diasorin
- Meridian Bioscience, Inc
- Quest Diagnostics
- Trinity Biotech
For more information visit http://www.researchandmarkets.com/research/9597nj/enteric_disease
